GPN Vaccines
Creating a comprehensive vaccine targeting Streptococcus pneumoniae, the leading bacterial pathogen worldwide.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD300m (Public information from Jun 2024)
Company register number 621789008
Adelaide South Australia (HQ)
Authorizing premium user...